Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,471.43p
   
  • Change Today:
    -3.57p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,601
  • Market Cap: £233.39m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
14.86% above the market average14.86% above the market average14.86% above the market average14.86% above the market average14.86% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
1yr Revenue Growth
0.75% below the market average0.75% below the market average0.75% below the market average0.75% below the market average0.75% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
6.28% below the market average6.28% below the market average6.28% below the market average6.28% below the market average6.28% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
1yr DPS Growth
60.82% above the market average60.82% above the market average60.82% above the market average60.82% above the market average60.82% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
55.51% above the market average55.51% above the market average55.51% above the market average55.51% above the market average55.51% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Book Ratio
96.83% below the market average96.83% below the market average96.83% below the market average96.83% below the market average96.83% below the market average
91.84% below the sector average91.84% below the sector average91.84% below the sector average91.84% below the sector average91.84% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
37.77% below the market average37.77% below the market average37.77% below the market average37.77% below the market average37.77% below the market average
1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average
Price Chg 3m
36.22% above the market average36.22% above the market average36.22% above the market average36.22% above the market average36.22% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
17.69% below the market average17.69% below the market average17.69% below the market average17.69% below the market average17.69% below the market average
5.66% above the sector average5.66% above the sector average5.66% above the sector average5.66% above the sector average5.66% above the sector average
Momentum 20
97.37% below the market average97.37% below the market average97.37% below the market average97.37% below the market average97.37% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
74.84% above the market average74.84% above the market average74.84% above the market average74.84% above the market average74.84% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average
ROCE
82.02% above the market average82.02% above the market average82.02% above the market average82.02% above the market average82.02% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
92.27% above the market average92.27% above the market average92.27% above the market average92.27% above the market average92.27% above the market average
92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average
Forecast EPS
82.61% above the market average82.61% above the market average82.61% above the market average82.61% above the market average82.61% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.01% below the market average35.01% below the market average35.01% below the market average35.01% below the market average35.01% below the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average
Operating Profit Loss
28.04% above the market average28.04% above the market average28.04% above the market average28.04% above the market average28.04% above the market average
70.37% above the sector average70.37% above the sector average70.37% above the sector average70.37% above the sector average70.37% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
27.64% below the market average27.64% below the market average27.64% below the market average27.64% below the market average27.64% below the market average
13.21% above the sector average13.21% above the sector average13.21% above the sector average13.21% above the sector average13.21% above the sector average
Cash
15.55% below the market average15.55% below the market average15.55% below the market average15.55% below the market average15.55% below the market average
Sector averageSector averageSector averageSector averageSector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
78.00% above the market average78.00% above the market average78.00% above the market average78.00% above the market average78.00% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Buys 1y
55.7% below the market average55.7% below the market average55.7% below the market average55.7% below the market average55.7% below the market average
80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,471.43p
Change Today -3.57p
% Change -0.08 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 1,601
Shares Issued 5.22m
Market Cap £233.39m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.56% above the market average78.56% above the market average78.56% above the market average78.56% above the market average78.56% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average
Income
30.49% below the market average30.49% below the market average30.49% below the market average30.49% below the market average30.49% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
35.7% below the market average35.7% below the market average35.7% below the market average35.7% below the market average35.7% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 24-Apr-2024

Time Volume / Share Price
13:40 190 @ 4,469.00p
13:08 196 @ 4,475.00p
13:08 201 @ 4,475.00p
13:07 201 @ 4,475.00p
13:07 201 @ 4,475.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page